method pharmacoepidemiologic analysis Medicaid method pharmacoepidemiologic data analysis Medicaid data cohort design Medicaid drugs similar underlying conditions period time Medicaid service transactions evident individual eligible selection cohort Selection study subjects descriptions cohorts Medicaid service histories preliminary prerequisite period Time risk prescription study drug refill prescription alternative drug therapeutic class predetermined number days Subjects time relevant health care transactions suggestive suspected adverse drug reactions Incidence densities prescriptions sequential courses therapy Methods accuracy case ascertainment briefly Separate validation studies validity computerized case ascertainment methods misclassification outcome method estimates risk outcomes outcomes data method useful feasibility customized studies 